Sharadha Subramanian

This inventor holds 26 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Kinase Inhibitors. Top assignees: Novartis Vaccines & Diagnostics, Gmbh, Novartis Ag, Chiron Corporation. Active years: 2002-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sharadha Subramanian. Retrieved from https://idiyas.com/inventor/sharadha-subramanian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 4)

% Patents Active = 42.3

CIPO Patents = 2

EPO Patents = 8 (Patent Applications = 6)

Average Co-Inventor Count = 9.9

ph-index = 10

Forward Citations = 250(Granted Patents)

Location History:

Emeryville, CA (US) (2009 - 2019)
San Ramon, CA (US) (2002 - 2020)

Company Filing History:

11 out of 245

Novartis Vaccines & Diagnostics, Gmbh

Years Active: 2002-2020

Loading Chart...

Areas of Expertise:

Biaryl Amide Compounds

Kinase Inhibitors

RAF Kinase

Substituted Pyrrolo

Imidazole Derivatives

Glycogen Synthase

Benzimidazoles

Quinazolines

Benzazoles

PDK1 Inhibition

Carbocycle Inhibitors

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10709712 - Biaryl amide compounds as kinase inhibitors (2020-07-14),

2. 10392404 - Compounds and compositions as kinase inhibitors (2019-08-27),

3. 10245267 - Biaryl amide compounds as kinase inhibitors (2019-04-02),

4. 10167279 - Compounds and compositions as RAF kinase inhibitors (2019-01-01),

5. 9694016 - Biaryl amide compounds as kinase inhibitors (2017-07-04),

6. 9546173 - Substituted pyrrolo[3,4-d]pyrimidines as kinase inhibitors (2017-01-17),

7. 8735599 - Substituted imidazole derivates (2014-05-27),

8. 8614330 - Substituted benz-azoles and methods of their use as inhibitors of RAF kinase (2013-12-24),

9. 8592459 - Substituted benzimidazoles and methods of their use (2013-11-26),

10. 8415382 - Substituted benzazoles and methods of their use as inhibitors of RAF Kinase (2013-04-09),

11. 8318791 - Substituted imidazole derivatives (2012-11-27),

12. 8299108 - Substituted benzazoles and methods of their use as inhibitors of raf kinase (2012-10-30),

13. 7932262 - Quinazolines for PDK1 inhibition (2011-04-26),

14. 7732465 - Substituted benzimidazoles and methods of their use (2010-06-08),

15. 7728010 - Substituted benz-azoles and methods of their use as inhibitors of Raf kinase (2010-06-01),

Title: The Innovative Mind of Sharadha Subramanian

Introduction: Sharadha Subramanian, a talented inventor based in San Ramon, CA, is known for his groundbreaking contributions to the field of technology and innovation. With a passion for creating solutions to complex problems, he has made a significant impact on various industries.

Latest Patents: Sharadha Subramanian's latest patents showcase his ingenuity and forward-thinking approach to innovation. His recent inventions have focused on improving efficiency in renewable energy systems and enhancing cybersecurity measures for digital platforms.

Career Highlights: Throughout his illustrious career, Sharadha Subramanian has held key roles in leading tech companies, where he has spearheaded research and development projects that have led to groundbreaking inventions. His expertise in areas such as artificial intelligence and data analytics has set him apart as a visionary in the tech world.

Collaborations: Sharadha Subramanian has collaborated with top researchers, engineers, and scientists from around the globe to bring his innovative ideas to life. His ability to work effectively in multidisciplinary teams has resulted in the successful development of cutting-edge technologies that have revolutionized the way we approach challenges in the digital age.

Conclusion: In conclusion, Sharadha Subramanian's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible have established him as a true trailblazer in the world of technology. His passion for creating solutions that make a difference continues to inspire others in the industry to think

Profile summary based on public USPTO records.